Concordia Healthcare Corp. T.CXR.R

FT article

[Pj1958]

is distorting to the public the price hikes , and this kind of reporting borders on illegal behaviour. They state that the eye drops in question have gone up in price from 2 GBP to 29 GBP from May 2013 to April 2016. Thats 2. 5 years which CXR did not even own AMco. the article blames CXR for the price hikes , but they dont state how much they have increased since CXR took over AMco. That is terrible journalism...please tell us how much CXR increased the price by , and don't accuse CXR of these increases.CXR has said they are responsible in their price increases , and until someone has proof that they are increasing drugs by this multiple the they should be ignored. That goes for the other drugs that were mentioned in that article they were all increased over a 3 year period , in which CXR was not even involved....shame on FT for poor journalism.

[adamchess]

Yes, typical short and distort tactics. 

[Stockcoach1]

Not to mention that any drug increases in the UK  are approved and made in concert with the regulators. I guess the UK government is colluding with CXR and gouging together. Lol.

[adamchess]

It would be nice if BNN and FT were more responsible and contact the company for comments before helping to the spread the stories that the shorts are creating to help their cause. Concordia cannot be held responsible for price increases by AMCo before they acquired them from Cinven, both british firms and ignoring these prices were reviewed and approved by british healthcare authorities. Shame on